METHOD AND PHARMACEUTICAL COMPOSITION FOR TREATING APLASTIC ANEMIA - BEIJING FUTURESOURCE PHARMACEUTICAL TECH CO LTD

Title:

METHOD AND PHARMACEUTICAL COMPOSITION FOR TREATING APLASTIC ANEMIA

Document Type and Number:

WIPO Patent Application WO/2018/214860

Kind Code:

A1

Abstract:

The present invention provides a method and pharmaceutical composition for treating aplastic anemia, and specifically provides applying an S1PR1 signal inhibitor to an object in need to treat aplastic anemia.

More Like This:

JP4781549	Unsaturated carbasaccharide amine derivative and glycosidase inhibitor using it
JP2004527471	Stable skin conditioning composition containing a retinoid booster
WO/2017/197324	ADRENERGIC RECEPTOR MODULATING COMPOUNDS AND METHODS OF USING THE SAME

Inventors:

CONG YUWEN (CN)
SHAN YAJUN (CN)
LI ZHONGTANG (CN)

Application Number:

PCT/CN2018/087769

Publication Date:

November 29, 2018

Filing Date:

May 22, 2018

Export Citation:

Click for automatic bibliography generation Help

Assignee:

BEIJING FUTURESOURCE PHARMACEUTICAL TECH CO LTD (CN)

International Classes:

A61K31/133; A61P7/06

Foreign References:

CN100431534C	2008-11-12
CN1894225A	2007-01-10

Other References:

URBANO, M. ET AL.: "Modulators of the Sphingosine 1-Phosphate Receptor 1", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 23, 29 September 2013 (2013-09-29), XP028760172

Attorney, Agent or Firm:

NTD UNIVATION INTELLECTUAL PROPERTY AGENCY LTD. (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: METHOD AND DEVICE FOR ANALYZING MAN-MACHINE DIALOGUE DATA

Next Patent: BURNER DPF REGENERATION CONTROL AND DIAGNOSTIC DEVICE